Researchers have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

Five genetic risk markers for prostate cancer may allow physicians to adapt screening approaches for men at high-risk, particularly African-American men, according to new research.

Data from a large-scale prevention trial has shown no protective effect from vitamin E on prostate cancer or vitamin C supplementation on total cancer.

The use of aspirin and other non-steroidal anti-inflammatory drugs is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University.

A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. Scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year and place them at increased risk for osteoporosis and fractures.

Scientists report on the evidence of a relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men enrolled in the REDUCE trial.